Metformin Versus Vildagliptin in Reducing Risk of Metabolic Syndrome Complications Progression

Conditions:   Metabolic Syndrome;   Diabete Type 2;   Kidney Insufficiency Interventions:   Drug: Vildagliptin;   Drug: Captopril Tablets;   Drug: MetFORMIN 500 Mg Oral Tablet Sponsor:   Cairo University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials